Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Greenblatt

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Calcified Tissue International|April 18, 2022
Troubling Aspects of the Trabecular Bone Score Adjustment for the Fracture Risk Assessment Tool (FRAX®)Martin Mayer, Aaron Greenblatt
Neural Networks : the Official Journal of the International Neural Network Society|November 13, 2012
The No-Prop algorithm: a new learning algorithm for multilayer neural networksBernard Widrow, Aaron Greenblatt, Youngsik Kim, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|October 6, 2025
The intersection of aging, pain, and opioid use disorder: a retrospective chart review from an outpatient opioid treatment clinicBethea A Kleykamp, Hannah Smith, Erin Lynch, et al.
Brain, Behavior, and Immunity|February 1, 2020
Blood-borne and brain-derived microparticles in morphine-induced anti-nociceptive toleranceDeepa Ruhela, Veena M Bhopale, Ming Yang, et al.
Substance Use & Misuse|September 13, 2024
On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical TrialsEric D Wish, Amy S Billing, Ebonie Massey, et al.
JAMA Network Open|August 27, 2021
Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use DisorderEric Weintraub, Chamindi Seneviratne, Jessica Anane, et al.
BMC Health Services Research|December 13, 2025
"Majority of the time, I know I'm right": understanding the decisions behind persistently high ED utilization among patients with substance use disordersMarik Moen, J David Gatz, Benoit Stryckman, et al.
Heroin Addiction and Related Clinical Problems|July 29, 2024
The impact of chronic pain and depression on medication for opioid use disorder treatment: A mixed-methods analysisCorinne N Kacmarek, Hannah C Smith, Maxwell Kuehn, et al.
Addiction (Abingdon, England)|July 9, 2024
Dose-specific clinical outcomes in patients with opioid use disorder treated with 24-32 mg/day of buprenorphineJulia D'Agata Mount, Junfeng Sun, Ashley Davis, et al.
Research Square|June 12, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Calcified Tissue International|April 18, 2022
Troubling Aspects of the Trabecular Bone Score Adjustment for the Fracture Risk Assessment Tool (FRAX®)Martin Mayer, Aaron Greenblatt
Neural Networks : the Official Journal of the International Neural Network Society|November 13, 2012
The No-Prop algorithm: a new learning algorithm for multilayer neural networksBernard Widrow, Aaron Greenblatt, Youngsik Kim, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|October 6, 2025
The intersection of aging, pain, and opioid use disorder: a retrospective chart review from an outpatient opioid treatment clinicBethea A Kleykamp, Hannah Smith, Erin Lynch, et al.
Brain, Behavior, and Immunity|February 1, 2020
Blood-borne and brain-derived microparticles in morphine-induced anti-nociceptive toleranceDeepa Ruhela, Veena M Bhopale, Ming Yang, et al.
Substance Use & Misuse|September 13, 2024
On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical TrialsEric D Wish, Amy S Billing, Ebonie Massey, et al.
JAMA Network Open|August 27, 2021
Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use DisorderEric Weintraub, Chamindi Seneviratne, Jessica Anane, et al.
BMC Health Services Research|December 13, 2025
"Majority of the time, I know I'm right": understanding the decisions behind persistently high ED utilization among patients with substance use disordersMarik Moen, J David Gatz, Benoit Stryckman, et al.
Heroin Addiction and Related Clinical Problems|July 29, 2024
The impact of chronic pain and depression on medication for opioid use disorder treatment: A mixed-methods analysisCorinne N Kacmarek, Hannah C Smith, Maxwell Kuehn, et al.
Addiction (Abingdon, England)|July 9, 2024
Dose-specific clinical outcomes in patients with opioid use disorder treated with 24-32 mg/day of buprenorphineJulia D'Agata Mount, Junfeng Sun, Ashley Davis, et al.
Research Square|June 12, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Pageof 2